Hedeker Wealth’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-11,263
Closed -$4.58M 87
2024
Q3
$4.58M Buy
11,263
+325
+3% +$119K 1.21% 32
2024
Q2
$3.51M Sell
10,938
-179
-2% -$58.2K 1.02% 38
2024
Q1
$3.71M Buy
11,117
+89
+0.8% +$27.2K 1.07% 37
2023
Q4
$2.98M Sell
11,028
-354
-3% -$87.5K 0.94% 41
2023
Q3
$2.8M Buy
11,382
+1,780
+19% +$487K 0.97% 40
2023
Q2
$2.91M Buy
9,602
+78
+0.8% +$21.7K 0.97% 43
2023
Q1
$2.51M Buy
9,524
+71
+0.8% +$18K 0.89% 55
2022
Q4
$2.27M Buy
9,453
+341
+4% +$76.4K 0.85% 52
2022
Q3
$1.67M Buy
9,112
+4,201
+86% +$837K 0.65% 61
2022
Q2
$967K Sell
4,911
-15,086
-75% -$3.24M 0.33% 71
2022
Q1
$5.01M Buy
19,997
+15,623
+357% +$3.92M 1.52% 25
2021
Q4
$1.12M Buy
4,374
+258
+6% +$63.1K 0.33% 69
2021
Q3
$999K Buy
+4,116
New +$1.01M 0.31% 71

Other funds holding HCA

Hedeker Wealth's HCA Position: Q4 2024 in Review

Hedeker Wealth sold out of HCA Healthcare (HCA) in Q4 2024, closing a stake of 11,263 shares — an estimated $4.58M sold.

Hedeker Wealth first reported a position in HCA in Q3 2021 and held it in 13 quarters. The position peaked at $5.01M in Q1 2022. 1,180 funds tracked by Wall St. Rank hold HCA as of Q4 2024.

  • Hedeker Wealth reported no remaining HCA Healthcare position as of Q4 2024 after selling out during the quarter.
  • Hedeker Wealth sold 11,263 HCA Healthcare shares in Q4 2024, an estimated $4.58M.
  • Hedeker Wealth first reported a position in HCA Healthcare in Q3 2021 and held it in 13 quarters.
  • Hedeker Wealth's HCA Healthcare position peaked at $5.01M in Q1 2022.
  • 1,180 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2024.

Based on Hedeker Wealth's 13F filing for Q4 2024, filed 27 Jan 2025.